With constructive regulation, Essential should be able to use its cash flow to fund most of its nonacquisition investment needs during the next five years. We expect only modest equity needs in the ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...